Vaccine firm will get $400,000 from Indiana Seed Fund

Bioscience Vaccines will receive an investment of $400,000 from the Indiana Seed Fund, which was set up by BioCrossroads to help life sciences firms. Bioscience plans to put the money toward a technology that can be used to develop adjuvants, which can boost the efficacy of vaccines.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide